Tiny Health, an Austin-based startup working to innovate the infant gut health space, has raised $8.5 million in a Series A funding round led by Spero Ventures. The round brings the company’s total funding to $13 million.
As rates of chronic health conditions such as eczema, asthma, diabetes and autoimmune diseases increase in children, Tiny Health works to detect and correct gut microbiome imbalances in the first 1,000 days of life. Its at-home tests use sequencing technology to analyze over 120,000 bacteria, fungi, viruses and parasites in the gut. By detecting gut microbiome imbalances early on, the company aims to help prevent and reverse chronic illnesses.
Alongside its infant gut health offerings, Tiny Health has come to include vaginal microbiome testing for expectant mothers. It also offers testing solutions for adults and children between the ages of three and 17. Since its launch in 2022, the company has recorded 25 percent month-over-month growth and has helped more than 25,000 families.
Its latest infusion of funding will help Tiny Health expand its platform to better support growing families across pediatrics, women’s health, metabolic health, adult chronic conditions and more.
